1.The diagnostic potential of Golgi protein 73 for cirrhosis in patients with chronic hepatitis C.
Peng Fei WANG ; Shu Hong LIU ; Xiang Jun QIAN ; Xiang Wei ZHAI ; Xia Jie WEN ; Ming Jie YAO ; Jing Min ZHAO ; Fengmin LU
Chinese Journal of Hepatology 2022;30(8):879-884
Objective: To explore the diagnostic value and model of serum Golgi protein 73 (GP73) in patients with hepatitis C cirrhosis. Methods: 271 cases with chronic hepatitis C virus infection who were treated in the Fifth Medical Center of PLA General Hospital from January 2010 to December 2017 were retrospectively collected as the research objects, including 126 cases with hepatitis and 145 cases with liver cirrhosis. Serum GP73 and liver stiffness measurement (LSM) based on transient elastography test were performed in all patients. Simultaneously, blood routine, liver function, coagulation function and other related indicators were collected. GP73 diagnostic efficiency for liver cirrhosis was evaluated by receiver operating characteristic curve (ROC). GP73 diagnostic value was clarified after comparison with aspartate aminotransferase/platelet ratio index (APRI), FIB-4 index (FIB-4) and LSM. Compensated hepatitis C virus-related cirrhosis diagnostic model based on serological index was established by logistic regression analysis. Results: The area under the receiver operating characteristic curve (AUC) of GP73, LSM, FIB-4 and APRI in the diagnosis of compensated hepatitis C virus-related cirrhosis were 0.923, 0.839, 0.836 and 0.800 respectively, and GP73 had the best diagnostic efficiency (P <0.001). LSM and GP73 combined use had improved the diagnostic sensitivity of cirrhosis to 97.24%. Multivariate logistic regression analysis revealed that GP73, age, and platelets were independent predictors of cirrhosis.Compensated hepatitis C virus-related cirrhosis diagnostic model (GAP) was established based on the result: LogitP=1/[1+exp(6.145+0.013×platelet-0.059×age-0.059×GP73)].AUC model for diagnosing compensated liver cirrhosis was 0.944, and the optimal cut-off value was 0.56, with sensitivity and specificity of 84.03% and 92.06%, respectively, and the diagnostic efficiency of this model was better than that of APRI, FIB-4, LSM and GP73 alone (P<0.05). Conclusion: GP73 is a reliable serum biomarker for the diagnosis of compensated hepatitis C virus-related cirrhosis. The GAP diagnostic model based on GP73, platelet count, and age can further improve the diagnostic efficiency and help to diagnose patients with compensated hepatitis C virus-related cirrhosis.
Aspartate Aminotransferases
;
Biomarkers
;
Fibrosis
;
Hepatitis C
;
Hepatitis C, Chronic/complications*
;
Humans
;
Infant, Newborn
;
Liver/pathology*
;
Liver Cirrhosis/pathology*
;
Polyesters
;
ROC Curve
;
Retrospective Studies
2.Polymorphism and liver fibrosis.
Chinese Journal of Hepatology 2012;20(8):565-567
Disease Progression
;
Fatty Liver
;
complications
;
genetics
;
pathology
;
Genotype
;
Hepatitis B, Chronic
;
complications
;
genetics
;
pathology
;
Hepatitis C, Chronic
;
complications
;
genetics
;
pathology
;
Humans
;
Liver Cirrhosis
;
etiology
;
genetics
;
pathology
;
Polymorphism, Single Nucleotide
3.Detection of lymphoma-like lesions in the liver of hepatitis C virus-infected patients.
He-bin FAN ; You-fu ZHU ; An-shen CHEN ; Mu-xiu ZHOU ; Ai-hua WU ; Fu-ming YAN ; Xiao-ju MA ; Hao ZHOU
Chinese Journal of Hepatology 2009;17(8):626-627
Adult
;
Aged
;
B-Lymphocytes
;
pathology
;
Female
;
Gastric Mucosa
;
pathology
;
Hepatitis B, Chronic
;
complications
;
epidemiology
;
virology
;
Hepatitis C, Chronic
;
complications
;
epidemiology
;
virology
;
Humans
;
Immunohistochemistry
;
Liver
;
pathology
;
Lymphoma
;
etiology
;
pathology
;
virology
;
Male
;
Middle Aged
;
Staining and Labeling
5.Transient elastography, true or false?.
The Korean Journal of Hepatology 2009;15(4):431-437
No abstract available.
Biopsy
;
Elasticity
;
*Elasticity Imaging Techniques
;
Fatty Liver/complications
;
Hepatitis B, Chronic/complications
;
Hepatitis C, Chronic/complications
;
Humans
;
Inflammation/complications
;
Liver Cirrhosis/etiology/pathology/*ultrasonography
;
Risk Factors
;
Severity of Illness Index
6.Assessment of disease activity and liver fibrosis in chronic viral hepatitis by magnetic resonance diffusion-weighted imaging.
Yang YANG ; Bin SONG ; Bi WU ; Xue-Zhong LEI
Acta Academiae Medicinae Sinicae 2009;31(2):155-159
OBJECTIVETo investigate the diagnostic value of magnetic resonance diffusion-weighted imaging (DWI) technique in assessing the disease activity and liver fibrosis of chronic viral hepatitis.
METHODSA total of 49 patients with chronic viral hepatitis who received liver biopsy and 10 healthy volunteers were included in this study. All of them underwent DWI on a 3.0 T magnetic resonance imaging system. When the gradient factor b value was set at 100, 200, 400, 600, and 800 s/mm2, the apparent diffusion coefficient (ADC) of the liver was measured respectively. Biopsy specimens were scored for necroinflammation and liver fibrosis according to the Knodell histological activity index.
RESULTSThe ADC values of the right lobe in both controls and patients were lower than those of the left lobe. When the b value was set at 400, 600, and 800 s/mm2, the differences of the ADC values between the fibrosis group (n = 36) and the non-fibrosis group (n = 23, including 10 cases of normal subjects) were statistically significant (P < 0.01). When the b value was set at 800 s/mm2, the ADC values among the different degrees of necroinflammation and grades of liver fibrosis were also significantly different (P < 0.05, P < 0.01).
CONCLUSIONDWI is a valuable method for in vivo and noninvasive assessment of the disease activity and liver fibrosis of chronic viral hepatitis.
Adolescent ; Adult ; Case-Control Studies ; Diffusion Magnetic Resonance Imaging ; methods ; Female ; Hepatitis B, Chronic ; complications ; pathology ; Hepatitis C, Chronic ; complications ; pathology ; Humans ; Liver Cirrhosis ; diagnosis ; etiology ; pathology ; Male ; Middle Aged ; Young Adult
7.Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues.
Jeong Hee YOON ; Joong Won PARK ; Jeong Min LEE
Korean Journal of Radiology 2016;17(1):7-24
Hepatocellular carcinoma (HCC) can be diagnosed based on characteristic findings of arterial-phase enhancement and portal/delayed "washout" in cirrhotic patients. Several countries and major academic societies have proposed varying specific diagnostic criteria for HCC, largely reflecting the variable HCC prevalence in different regions and ethnic groups, as well as different practice patterns. In 2014, a new version of Korean practice guidelines for management of HCC was released by the Korean Liver Cancer Study Group (KLCSG) and the National Cancer Center (NCC). According to the KLCSG-NCC Korea practice guidelines, if the typical hallmark of HCC (i.e., hypervascularity in the arterial phase with washout in the portal or 3 min-delayed phases) is identified in a nodule > or = 1 cm in diameter on either dynamic CT, dynamic MRI, or MRI using hepatocyte-specific contrast agent in high-risk groups, a diagnosis of HCC is established. In addition, the KLCSG-NCC Korea practice guidelines provide criteria to diagnose HCC for subcentimeter hepatic nodules according to imaging findings and tumor marker, which has not been addressed in other guidelines such as Association for the Study of Liver Diseases and European Association for the Study of the Liver. In this review, we briefly review the new HCC diagnostic criteria endorsed by the 2014 KLCSG-NCC Korea practice guidelines, in comparison with other recent guidelines; we furthermore address several remaining issues in noninvasive diagnosis of HCC, including prerequisite of sonographic demonstration of nodules, discrepancy between transitional phase and delayed phase, and implementation of ancillary features for HCC diagnosis.
Aged
;
Aged, 80 and over
;
Carcinoma, Hepatocellular/*diagnosis/pathology
;
Contrast Media
;
Female
;
Hepatitis B, Chronic/complications
;
Hepatitis C, Chronic/complications
;
Humans
;
Liver/*pathology
;
Liver Neoplasms/*diagnosis/pathology
;
Magnetic Resonance Imaging/*methods
;
Male
;
Middle Aged
;
Practice Guidelines as Topic
;
Republic of Korea
;
Young Adult
8.An ultrasonographic scoring system for screening compensated liver cirrhosis in patients with chronic hepatitis B and C virus infection.
Xiao-ling LI ; Yong-peng CHEN ; Lin DAI ; You-fu ZHU ; Xiao-ke LUO ; Jin-lin HOU
Journal of Southern Medical University 2006;26(8):1200-1208
OBJECTIVETo investigate the correlation between the stage of hepatic fibrosis and ultrasonographic findings of the liver, spleen and gallbladder and establish a sensitive ultrasonographic semi-quantitative scoring system for screening compensated liver cirrhosis.
METHODSTotalling 248 patients with chronic hepatitis B and hepatitis C virus infection underwent liver biopsy and ultrasonic examination. The images of the liver surface, parenchymal echo, intrahepatic vessels, gallbladder, spleen and diameter of portal vein were analyzed.
RESULTSThe stages of hepatic fibrosis were not correlated to ultrasonographic findings of the liver surface or diameter of portal vein, but hepatic fibrosis of different stages showed significant differences in parenchymal echo, intrahepatic vessels, gallbladder and splenomegaly. In cases with normal liver parenchymal, intrahepatic vessels, gallbladder and spleen, the negative predictive value of the ultrasonographic semi-quantitative scoring system for diagnosing compensated liver cirrhosis amounted to 96.3%. The sensitivity of a score not lower than 5 was 90% for detecting compensated cirrhosis. With a score not lower than 7, the diagnostic accuracy and specificity was 85.9% and 95.2%, respectively, but the sensitivity was lowered to 37.5%.
CONCLUSIONThe ultrasonic images of the liver parenchyma, intrahepatic vessels, gallbladder and spleen in patients with compensated liver cirrhosis vary significantly in patients with hepatic fibrosis of different stages, and this ultrasonographic scoring system allows for a sensitive diagnosis of compensated cirrhosis.
Female ; Fibrosis ; Gallbladder ; diagnostic imaging ; Hepatitis B, Chronic ; complications ; Hepatitis C ; complications ; Humans ; Liver ; diagnostic imaging ; pathology ; virology ; Liver Cirrhosis ; complications ; diagnosis ; Male ; Reproducibility of Results ; Sensitivity and Specificity ; Spleen ; diagnostic imaging ; Splenomegaly ; diagnostic imaging ; Ultrasonography ; methods
9.A Case of Cryptococcal Meningitis Mimicking Hepatic Encephalopathy in a Patient with Liver Cirrhosis Caused by Chronic Hepatitis C.
Hye Mi CHOI ; Gum Mo JUNG ; Woong Ki LEE ; Hyeuk Soo LEE ; Byung Sun KIM ; Choong Sil SEONG ; So Hee YOON ; Yong Keun CHO
The Korean Journal of Gastroenterology 2014;64(5):294-297
Cryptococcus neoformans, an encapsulated fungus, is an important opportunistic pathogen that can cause meningitis in immunocompromised patients. Since patients with cryptococcemia have high mortality, it is essential to make an early diagnosis and promptly initiate antifungal therapy. However, it is often very difficult to differentiate between cryptococcal meningitis and hepatic encephalopathy in patients with liver cirrhosis, and there is delay in making the diagnosis. Therefore, these patients have a particularly grave prognosis and consequently many patients die before culture results become available. In one study, starting antifungal therapy within 48 hours of the blood culture was associated with improved survival, but patients with liver cirrhosis were significantly less likely to receive antifungal therapy within 48 hours compared to those without liver cirrhosis. Recently, the authors experience a case of a 68-year-old woman with liver cirrhosis who presented with fever and a drowsy mental status. She had a previous history of having been admitted for infection-associated hepatic encephlopathy. Cryptococcal meningitis and cryptococcemia were diagnosed by spinal puncture and culture of cerebrospinal fluid. In spite of adequate treatment, the patient developed multi-system organ failure and eventually expired. Herein, we report a case of cryptococcal meningitis mimicking hepatic encephalopathy in a patient with liver cirrhosis.
Aged, 80 and over
;
Brain/radiography
;
Cryptococcus/isolation & purification
;
Female
;
Hepatic Encephalopathy/complications/*diagnosis
;
Hepatitis C, Chronic/complications/pathology
;
Humans
;
Liver Cirrhosis/etiology/pathology
;
Meningitis, Cryptococcal/complications/*diagnosis/microbiology
;
Tomography, X-Ray Computed
10.Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease.
Chansik AN ; Youn Ah CHOI ; Dongil CHOI ; Yong Han PAIK ; Sang Hoon AHN ; Myeong Jin KIM ; Seung Woon PAIK ; Kwang Hyub HAN ; Mi Suk PARK
Clinical and Molecular Hepatology 2015;21(3):279-286
BACKGROUND/AIMS: The goal of this study was to estimate the growth rate of hepatocellular carcinoma (HCC) and identify the host factors that significantly affect this rate. METHODS: Patients with early-stage HCC (n=175) who underwent two or more serial dynamic imaging studies without any anticancer treatment at two tertiary care hospitals in Korea were identified. For each patient, the tumor volume doubling time (TVDT) of HCC was calculated by comparing tumor volumes between serial imaging studies. Clinical and laboratory data were obtained from the medical records of the patients. RESULTS: The median TVDT was 85.7 days, with a range of 11 to 851.2 days. Multiple linear regression revealed that the initial tumor diameter (a tumor factor) and the etiology of chronic liver disease (a host factor) were significantly associated with the TVDT. The TVDT was shorter when the initial tumor diameter was smaller, and was shorter in HCC related to hepatitis B virus (HBV) infection than in HCC related to hepatitis C virus (HCV) infection (median, 76.8 days vs. 137.2 days; P=0.0234). CONCLUSIONS: The etiology of chronic liver disease is a host factor that may significantly affect the growth rate of early-stage HCC, since HBV-associated HCC grows faster than HCV-associated HCC.
Adult
;
Aged
;
Aged, 80 and over
;
Antiviral Agents/therapeutic use
;
Carcinoma, Hepatocellular/complications/*pathology/radiography
;
Demography
;
Female
;
Hepatitis B, Chronic/*complications/drug therapy
;
Hepatitis C, Chronic/*complications/drug therapy
;
Humans
;
Linear Models
;
Liver Neoplasms/complications/*pathology/radiography
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Neoplasm Staging
;
Republic of Korea
;
Retrospective Studies
;
Tertiary Care Centers
;
Tomography, X-Ray Computed